↓ Skip to main content

Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority

Overview of attention for article published in Frontiers in Pharmacology, August 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority
Published in
Frontiers in Pharmacology, August 2022
DOI 10.3389/fphar.2022.972660
Pubmed ID
Authors

Stéphane Vignot, Alban Dhanani, Isabelle Sainte-Marie, Laure de Ligniville Lajavardi, Gwennaelle Even, Muriel Echemann, Nina Hulin, Claire Ménoret, Patrick Maison, Christelle Ratignier-Carbonneil

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1 9%
Student > Master 1 9%
Unknown 9 82%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 1 9%
Medicine and Dentistry 1 9%
Unknown 9 82%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2022.
All research outputs
#17,954,835
of 23,056,273 outputs
Outputs from Frontiers in Pharmacology
#7,232
of 16,382 outputs
Outputs of similar age
#279,700
of 430,309 outputs
Outputs of similar age from Frontiers in Pharmacology
#495
of 1,382 outputs
Altmetric has tracked 23,056,273 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,382 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,309 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,382 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.